☰

Carissa R. Moore, Ph.D. - Publications

Affiliations: 
2006 University of Iowa, Iowa City, IA 
Area:
Immunology
Tree Info Grants Similar researchers PubMed Report error

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Edwards SK, Han Y, Liu Y, Kreider BZ, Liu Y, Grewal S, Desai A, Baron J, Moore CR, Luo C, Xie P. Signaling mechanisms of bortezomib in TRAF3-deficient mouse B lymphoma and human multiple myeloma cells. Leukemia Research. PMID 26740054 DOI: 10.1016/J.Leukres.2015.12.005  0.417
2015 Moore CR, Edwards SK, Xie P. Targeting TRAF3 Downstream Signaling Pathways in B cell Neoplasms. Journal of Cancer Science & Therapy. 7: 67-74. PMID 25960828 DOI: 10.4172/1948-5956.1000327  0.484
2015 Lalani AI, Moore CR, Luo C, Kreider BZ, Liu Y, Morse HC, Xie P. Myeloid cell TRAF3 regulates immune responses and inhibits inflammation and tumor development in mice. Journal of Immunology (Baltimore, Md. : 1950). 194: 334-48. PMID 25422508 DOI: 10.4049/Jimmunol.1401548  0.399
2014 Xie P, Moore CR, Swerdel MR, Hart RP. Transcriptomic profiling of splenic B lymphomas spontaneously developed in B cell-specific TRAF3-deficient mice. Genomics Data. 2: 386-388. PMID 25419513 DOI: 10.1016/J.Gdata.2014.10.017  0.412
2014 Edwards SK, Baron J, Moore CR, Liu Y, Perlman DH, Hart RP, Xie P. Mutated in colorectal cancer (MCC) is a novel oncogene in B lymphocytes. Journal of Hematology & Oncology. 7: 56. PMID 25200342 DOI: 10.1186/S13045-014-0056-6  0.484
2014 Edwards SK, Desai A, Liu Y, Moore CR, Xie P. Expression and function of a novel isoform of Sox5 in malignant B cells. Leukemia Research. 38: 393-401. PMID 24418753 DOI: 10.1016/J.Leukres.2013.12.016  0.456
2013 Edwards SK, Moore CR, Liu Y, Grewal S, Covey LR, Xie P. N-benzyladriamycin-14-valerate (AD 198) exhibits potent anti-tumor activity on TRAF3-deficient mouse B lymphoma and human multiple myeloma. Bmc Cancer. 13: 481. PMID 24131623 DOI: 10.1186/1471-2407-13-481  0.42
2012 Moore CR, Liu Y, Shao C, Covey LR, Morse HC, Xie P. Specific deletion of TRAF3 in B lymphocytes leads to B-lymphoma development in mice. Leukemia. 26: 1122-7. PMID 22033491 DOI: 10.1038/Leu.2011.309  0.411
2012 Edwards SKE, Desai A, Moore CR, Liu Y, Hart RP, Xie P. Abstract LB-272: A novel isoform of Sox5 is expressed in TRAF3-deficient mouse B lymphomas Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-272  0.367
2009 Graham JP, Moore CR, Bishop GA. Roles of the TRAF2/3 binding site in differential B cell signaling by CD40 and its viral oncogenic mimic, LMP1. Journal of Immunology (Baltimore, Md. : 1950). 183: 2966-73. PMID 19667091 DOI: 10.4049/Jimmunol.0900442  0.689
2007 Bishop GA, Moore CR, Xie P, Stunz LL, Kraus ZJ. TRAF proteins in CD40 signaling. Advances in Experimental Medicine and Biology. 597: 131-51. PMID 17633023 DOI: 10.1007/978-0-387-70630-6_11  0.459
2006 Xie P, Hostager BS, Munroe ME, Moore CR, Bishop GA. Cooperation between TNF receptor-associated factors 1 and 2 in CD40 signaling. Journal of Immunology (Baltimore, Md. : 1950). 176: 5388-400. PMID 16622006 DOI: 10.4049/Jimmunol.176.9.5388  0.729
2005 Moore CR, Bishop GA. Differential regulation of CD40-mediated TNF receptor-associated factor degradation in B lymphocytes. Journal of Immunology (Baltimore, Md. : 1950). 175: 3780-9. PMID 16148124 DOI: 10.4049/Jimmunol.175.6.3780  0.707
Show low-probability matches.